Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice.
Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis.
Anti-integrin therapy for multiple sclerosis.
Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous system.
Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter.
Towards establishing MS prevalence in Latin America and the Caribbean.
From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development.
Behavioral interventions in multiple sclerosis: a biopsychosocial perspective.
Genetic burden of common variants in progressive and bout-onset multiple sclerosis.
Safety and efficacy extension study of daclizumab high yield process (DAC HYP) to treat relapsing remitting multiple sclerosis
Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility.
IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotection.
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis.
Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.
Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-Aquaporin 4 antibodies.
Psychiatric disorders in neurology.
Testing the feasibility and acceptability of using the Nintendo Wii in the home to increase activity levels, vitality and well-being in people with multiple sclerosis (Mii-vitaliSe): protocol for a pilot randomised controlled study.
Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System.
Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro.
Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses.
Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.
Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells.
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo.

Pages